Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Pain, Postoperative 3 Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Pancreatic Neoplasms 2 Pain 2 Colonic Neoplasms 2 Choledocholithiasis 2 Choledochal Cyst 2 Anxiety Disorders 2 Urinary Bladder Neoplasms 1 Terminal Cancer 1 Stomach Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sedation 1 Rectal Neoplasms 1 Postoperative Cognitive Complications 1 Polyps 1 Personal Satisfaction 1 Patient Satisfaction 1 Parasomnias 1 Pancreatitis 1 Pain, Intractable 1 Opioid-Related Disorders 1 Nausea 1 Mouth Neoplasms 1 Healthy 1 Glioma 1

Interventions

Midazolam 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Terminal Cancer × Midazolam × Clear all

NCT02009306 2018-05-09

Nasal Fentanyl and Buccal Midazolam for Dying Patients

Gloucestershire Hospitals NHS Foundation Trust

Phase 4 Completed

Terminal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡